Australia Looks Into Funding Diagnostics For Targeted Drugs
This article was originally published in PharmAsia News
Executive Summary
Australian authorities believe they may be able to save billions of dollars by backing development of diagnostic tests for targeted drugs. The government plans to explore the possibility of such a move, which could have an added advantage of preventing harmful side effects. The Australian Centre for Health Research estimated possible savings at more than U.S. $8.5 billion over the next five years. The study, conducted for the center by Deloitte Economics, named strokes, cholesterol, colorectal cancer and depression as among several diseases and drugs that would benefit from targeting. (Click here for more